Regulation and Dysfunction of Apoptosis

The book provides a comprehensive review of apoptotic cell death. It discusses the mechanism of apoptosis and emerging principles of drug resistance in cancer. The development of novel drug targets and drug delivery systems for inhibiting or inducing apoptosis are the ultimate goal. Further, upregul...

Full description

Bibliographic Details
Main Author: Tutar, Yusuf
Format: eBook
Language:English
Published: IntechOpen 2022
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 02158nma a2200301 u 4500
001 EB002051880
003 EBX01000000000000001195546
005 00000000000000.0
007 cr|||||||||||||||||||||
008 220822 ||| eng
020 |a 9781839691959 
020 |a 9781839691935 
020 |a intechopen.92915 
020 |a 9781839691942 
100 1 |a Tutar, Yusuf 
245 0 0 |a Regulation and Dysfunction of Apoptosis  |h Elektronische Ressource 
260 |b IntechOpen  |c 2022 
300 |a 1 electronic resource (182 p.) 
653 |a Cellular biology (cytology) 
653 |a Cellular biology (cytology) / bicssc 
700 1 |a Tutar, Yusuf 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/ 
028 5 0 |a 10.5772/intechopen.92915 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/90238  |z DOAB: description of the publication 
856 4 0 |u https://mts.intechopen.com/storage/books/10541/authors_book/authors_book.pdf  |7 0  |x Verlag  |3 Volltext 
520 |a The book provides a comprehensive review of apoptotic cell death. It discusses the mechanism of apoptosis and emerging principles of drug resistance in cancer. The development of novel drug targets and drug delivery systems for inhibiting or inducing apoptosis are the ultimate goal. Further, upregulation of anti-apoptotic proteins and loss of pro-apoptotic proteins strongly favors apoptosis evasion. The ability of cancer cells to evade apoptosis is critical for the progression and clonal expansion of malignantly transformed cells. Defective apoptosis imparts proliferative advantage to cancer cells or cells with the potential to become cancerous. The mechanisms employed by cancer cells to evade apoptosis can be used in the strategic design of therapeutic regimens aimed at exploiting apoptotic signaling networks to ensure tumor-specific cell death. This book presents knowledge of the molecular mechanisms of defective apoptosis that could be translated into the development of novel therapeutic agents and therapeutic modalities for cancer treatment.